ClinVar Miner

Submissions for variant NM_012208.4(HARS2):c.697C>T (p.Arg233Cys) (rs749799529)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000767024 SCV000251611 uncertain significance not provided 2017-11-03 criteria provided, single submitter clinical testing p.Arg233Cys (CGT>TGT): c.697 C>T in exon 7 of the HARS2 gene (NM_012208.2). The R233C variant has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. The R233C variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is moderately conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. Furthermore, multiple in-silico splice prediction models predict that the c.697 C>T nucleotide substitution, responsible for R233C, destroys or damages the natural splice acceptor site and results in the increased use of a downstream cryptic splice site which would be expected to result in abnormal gene splicing. However, the true effect of c.697 C>T on splicing in vivo is not known without functional studies. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic mutation or a rare benign variant. The variant is found in MITONUC-MITOP panel(s).
Laboratory for Molecular Medicine, Partners HealthCare Personalized Medicine RCV000199488 SCV000271838 uncertain significance not specified 2016-05-01 criteria provided, single submitter clinical testing Variant classified as Uncertain Significance - Favor Pathogenic. The p.Arg233Cys variant in HARS2 has been reported by our laboratory in one individual with hea ring loss who was compound heterozygous for a second variant of uncertain signif icance in the HARS2 gene (this family). This variant has been identified in 1/6 6456 European chromosomes and 1/16468 South Asian chromosomes by the Exome Aggre gation Consortium (ExAC, Although this variant has been seen in the general population, its frequency is not high enough to rul e out a pathogenic role. Computational prediction tools suggest that the p.Arg23 3Cys variant may impact the protein, though this information is not predictive e nough to determine pathogenicity. In summary, while there is some suspicion for a pathogenic role, the clinical significance of the p.Arg233Cys variant is uncer tain.
CeGaT Praxis fuer Humangenetik Tuebingen RCV000767024 SCV001500369 uncertain significance not provided 2020-07-01 criteria provided, single submitter clinical testing
OMIM RCV001261944 SCV001439295 pathogenic Perrault syndrome 2 2020-10-26 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.